HOW CAN WE ENHANCE THE VASCULAR TOOLKIT

Friday, October 27, 2023

15:15 – 16:15 EST

Location: Palais, 516DE

Co-Chair(s)

Marie-Pier Arsenault, MD, MSc, FRCPC, DRCPSC (she/her/hers)

Physician
Hôpital Maisonneuve-Rosemont, Université de Montréal
Université de Montréal
Anne-Sophie Brazeau, PDt, PhD

Assistant professor
École de Nutrition Humaine
McGill University
McGill University

Planning Committee Member(s)

Sonia Anand, MD, PhD, FRCPc, FRSC (she/her/hers)

Professor of Medicine & Epidemiology
McMaster University
McMaster University

Disclosure(s):

Marie-Pier Arsenault, MD, MSc, FRCPC, DRCPSC: Thrombose Canada: Speaker/Honoraria (Ongoing)

Anne-Sophie Brazeau, PDt, PhD: Canadian Institute for Health Research: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Dexcom: Speaker/Honoraria (Terminated, January 31, 2023); Diabète Québec: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Fonds de recherche du Québec en Santé: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Juvenile Diabetes Research Foundation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Mitacs: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Sonia Anand, MD, PhD, FRCPc, FRSC: Bayer AG: Speaker/Honoraria (Ongoing); Daiichi Sankyo: Speaker/Honoraria (Ongoing); Janssen Inc.: Speaker/Honoraria (Ongoing); Servier: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

desribe the use of multi OMIC risk scores in CVD diagnosis;
list the use of vascular ultrasound in clinic for atherosclerosis diagnosis; and
describe how remote monitoring can reduce hospital stay and improve safety in patients after cardiac surgery.

Session Description: What are the new and novel tools used today for CVD diagnosis?

Presentations:

15:15 – 15:30 EST

POLYGENIC RISK SCORES
Presenter: Guillaume Pare, MD, MSc (he/him/his) – McMaster University
15:30 – 15:45 EST

REMOTE MONITORING AND SENSORS AFTER CARDIAC SURGERY
Presenter: Michael McGillion – McMaster University
15:45 – 16:00 EST

USE OF POCUS TO MEASURE ATHEROSCLEROSIS IN OUTPATIENT CLINICS - A RISK STRATIFIER
Presenter: Amer M. Johri, MSc MD FRCPC (he/him/his) – CSE
16:00 – 16:15 EST

PANEL DISCUSSION AND Q&A